Patent ID: 11919964
Assignee: AMGEN INC.
Field: Biotechnology (Chemistry)
Classification: CPC C  A | IPC C

Claim 24:
25. The bispecific heterodimeric antibody of claim 24, wherein:
(a) VL1 comprises the sequence of SEQ ID NO: 136 and VH1 comprises the sequence of SEQ ID NO: 190;
(b) VL1 comprises the sequence of SEQ ID NO: 137 and VH1 comprises the sequence of SEQ ID NO: 191;
(c) VL1 comprises the sequence of SEQ ID NO: 138 and VH1 comprises the sequence of SEQ ID NO: 192;
(d) VL1 comprises the sequence of SEQ ID NO: 139 and VH1 comprises the sequence of SEQ ID NO: 193;
(e) VL1 comprises the sequence of SEQ ID NO: 140 and VH1 comprises the sequence of SEQ ID NO: 194;
(f) VL1 comprises the sequence of SEQ ID NO: 141 and VH1 comprises the sequence of SEQ ID NO: 195;
(g) VL1 comprises the sequence of SEQ ID NO: 140 and VH1 comprises the sequence of SEQ ID NO: 196;
(h) VL1 comprises the sequence of SEQ ID NO: 141 and VH1 comprises the sequence of SEQ ID NO: 197;
(i) VL1 comprises the sequence of SEQ ID NO: 142 and VH1 comprises the sequence of SEQ ID NO: 194;
(j) VL1 comprises the sequence of SEQ ID NO: 143 and VH1 comprises the sequence of SEQ ID NO: 195;
(k) VL1 comprises the sequence of SEQ ID NO: 144 and VH1 comprises the sequence of SEQ ID NO: 194;
(l) VL1 comprises the sequence of SEQ ID NO: 145 and VH1 comprises the sequence of SEQ ID NO: 195;
(m) VL1 comprises the sequence of SEQ ID NO: 142 and VH1 comprises the sequence of SEQ ID NO: 196;
(n) VL1 comprises the sequence of SEQ ID NO: 143 and VH1 comprises the sequence of SEQ ID NO: 197;
(o) VL1 comprises the sequence of SEQ ID NO: 146 and VH1 comprises the sequence of SEQ ID NO: 198;
(p) VL1 comprises the sequence of SEQ ID NO: 147 and VH1 comprises the sequence of SEQ ID NO: 199;
(q) VL1 comprises the sequence of SEQ ID NO: 146 and VH1 comprises the sequence of SEQ ID NO: 200; or
(r) VL1 comprises the sequence of SEQ ID NO: 147 and VH1 comprises the sequence of SEQ ID NO: 201.